Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs

Breast Cancer Research and Treatment

Volumn 129, Issue 3, 2011, Pages 767-776

  Smeets, A ^a   Daemen, A ^b   Vanden Bempt, I ^c   Gevaert, O ^b,d   Claes, B ^e   Wildiers, H ^a   Drijkoningen, R ^f   Van Hummelen, P ^g   Lambrechts, D ^e   De Moor, B ^b   Neven, P ^a   Sotiriou, C ^h   Vandorpe, T ^a   Paridaens, R ^a   Christiaens, M R ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Katholieke Universiteit Leuven   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f JESSA HOSPITAL   (Belgium)

^g DANA FARBER CANCER INSTITUTE   (United States)

^h JULES BORDET INSTITUTE   (Belgium)

Author keywords

Breast cancer; Lymph node; Microarrays; miRNA; Prediction

Indexed keywords

MICRORNA;

ADULT; AGED; APOPTOSIS RELATED GENE; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC MODEL; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MULTIPLE KINASE GENE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; RNA ANALYSIS; SUPPORT VECTOR MACHINE; TUMOR GENE; ZINC ION BINDING GENE;

AGED; AREA UNDER CURVE; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; MODELS, GENETIC;

EID: 80052592927     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1265-5     Document Type: Article

References (50)

1. LL Shek W Godolphin 1988 Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis Cancer Res 48 5565 5569 3416309 1:STN:280:DyaL1czislOgtA%3D%3D
2. B Weigelt JL Peterse LJ van't Veer 2005 Breast cancer metastasis: markers and models Nat Rev Cancer 5 8 591 602 16056258 10.1038/nrc1670 1:CAS:528:DC%2BD2MXmvVCltrg%3D (Pubitemid 41081385)
3. I Jatoi SG Hilsenbeck GM Clark CK Osborne 1999 Significance of axillary lymph node metastasis in primary breast cancer J Clin Oncol 17 8 2334 2340 10561295 1:STN:280:DC%2BD3c%2FjtVShtg%3D%3D (Pubitemid 29368231)
4. I Mittra KD MacRae 1991 A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology of chronology? Eur J Cancer 27 12 1574 1583 1838260 10.1016/0277-5379(91)90418-D 1:STN:280:DyaK387ksVahtQ%3D%3D
5. B Fisher JH Jeong S Anderson J Bryant ER Fisher N Wolmark 2002 Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation N Engl J Med 347 8 567 575 12192016 10.1056/NEJMoa020128
6. S Koscielny MG Le M Tubiana 1989 The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases Br J Cancer 59 775 782 2736212 10.1038/bjc.1989.162 1:STN:280:DyaL1M3oslamtw%3D%3D (Pubitemid 19148543)
7. CH Yip NA Taib GH Tan KL Ng BK Yoong WY Choo 2009 Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? Word J Surg 33 54 57 10.1007/s00268-008-9782-7 1:STN:280: DC%2BD1M%2FhvFKquw%3D%3D
8. DE Rivadeneira RM Simmons PJ Christos K Hanna JM Daly MP Osborne 2000 Predictive factors associated with axillary lymph node metastases in T1a en T1b breast carcinomas: analysis in more than 900 patients J Am Coll Surg 191 1 1 6 10898177 10.1016/S1072-7515(00)00310-0 1:STN:280:DC%2BD3czlsVGnsA%3D%3D (Pubitemid 30439553)
9. H Wildiers B Van Calster LV van de Poll-Franse, et al. 2009 Relationship between age and axillary lymph node involvement in women with breast cancer J Clin Oncol 27 18 2931 2937 19451448 10.1200/JCO.2008.16.7619
10. C Sotiriou L Pusztai 2009 Gene-expression signatures in breast cancer N Engl J Med 360 790 800 19228622 10.1056/NEJMra0801289 1:CAS:528: DC%2BD1MXitFWqs70%3D
11. E Huang SH Cheng H Dressman, et al. 2003 Gene expression predictors of breast cancer outcomes Lancet 361 9369 1590 1596 12747878 10.1016/S0140-6736(03) 13308-9 1:CAS:528:DC%2BD3sXjs1Wltbo%3D (Pubitemid 36578995)
12. B Weigelt LFA Wessels AJ Bosma, et al. 2005 No common denominator for breast cancer lymph node metastasis Br J Cancer 93 8 924 932 16189523 10.1038/sj.bjc.6602794 1:CAS:528:DC%2BD2MXhtV2kt7vK (Pubitemid 41487019)
13. L He GJ Hannon 2004 MicroRNAs: small RNAs with a big role in gene regulation Nat Rev Genet 5 7 522 531 15211354 10.1038/nrg1379 1:CAS:528:DC%2BD2cXltVSmsbw%3D (Pubitemid 38868508)
14. EK Ng CLP Wong ES Ma A Kwong 2009 MircroRNAs as new players for diagnosis, prognosis and therapeutic targets in breast cancer J Oncol 2009 305420 19644558
15. HM Heneghan N Miller MJ Kerin 2010 MiRNAs as biomarkers and therapeutic targets in cancer Curr Opin Pharmacol 10 1 8 10.1016/j.coph.2010.05.010
16. D Martinez-Ramos J Escrig-Sos M Alcalde-Sanchez A Torrela-Ramos JL Salvador-Sanchis 2009 Disease-free survival and prognostic significance of metastatic lymph node ratio in T1-T2 N positive breast cancer patients. A population registry-based study in a European country World J Surg 33 1659 1664 19488815 10.1007/s00268-009-0078-3
17. Suykens JAK, Van Gestel T, De Brabanter J, De Moor B, Vandewalle J (2002) Least squares support vector machines. World Scientific, Singapore
18. JAK Suykens J Vandewalle 1999 Least squares support vector machine classifiers Neural Process Lett 9 293 300 10.1023/A:1018628609742
19. Cawley GC (2006) Leave-one-out cross-validation based model selection criteria for weighted LS-SVMs. Proc Int Joint Conf Neural Netw 1661-1668 (Pubitemid 351369522)
20. E Berezikov G vanTetering M Verheul, et al. 2006 Many novel mammalian microRNA candidates identified by extensive cloning and RAKE analysis Genome Res 16 1289 1298 16954537 10.1101/gr.5159906 1:CAS:528:DC%2BD28XhtVOmtrbJ (Pubitemid 44506962)
21. D Betel M Wilson A Gabow DS Marks C Sander 2008 The microRNA.org resource: targets and expression Nucleic Acids Res 36 D149 D153 18158296 10.1093/nar/gkm995 1:CAS:528:DC%2BD1cXhtVSrurg%3D (Pubitemid 351149712)
22. B Zhang D Schmoyer S Kirov J Snoddy 2004 GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies BMC Bioinformatics 5 16 14975175 10.1186/1471-2105-5-16 (Pubitemid 38751319)
23. A Subramanian P Tamayo VK Mootha, et al. 2005 Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc Natl Acad Sci U S A 102 43 15545 15550 16199517 10.1073/pnas.0506580102 1:CAS:528:DC%2BD2MXht1ShtrnO (Pubitemid 41528093)
24. M Hu K Polyak 2008 Microenvironmental regulation of cancer development Curr Opin Genet Dev 18 1 27 34 18282701 10.1016/j.gde.2007.12.006 1:CAS:528:DC%2BD1cXmsVartb8%3D (Pubitemid 351694443)
25. LCLT van Kempen DJ Ruiter GNP van Muijen LM Coussens 2003 The tumor microenvironment: a critical determinant of neoplastic evolution Eur J Cell Biol 82 11 539 558 14703010 10.1078/0171-9335-00346 (Pubitemid 38008835)
26. T Bogenrieder M Herlyn 2003 Axils of evil: molecular mechanisms of cancer metastasis Oncogene 22 42 6524 6536 14528277 10.1038/sj.onc.1206757 1:CAS:528:DC%2BD3sXnsl2rsr0%3D (Pubitemid 37372332)
27. BC Sheu WH Kuo RJ Chen SC Huang KJ Chang SN Chow 2008 Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer Breast 17 6 604 610 18656354 10.1016/j.breast.2008.06.001
28. AH Macchetti HRC Marana JS Silva JM de Andrade A Ribeiro-Silva S Bighetti 2006 Tumor-infiltrating CD4+T lymphocytes in early breast cancer reflect lymph node involvement Clinics 61 3 203 208 16832552 10.1590/S1807-59322006000300004 (Pubitemid 44047807)
29. R Simon 2005 Roadmap for developing and validating therapeutically relevant genomic classifiers J Clin Oncol 23 29 7332 7341 16145063 10.1200/JCO.2005.02.8712 1:CAS:528:DC%2BD2MXhtF2nsLrP (Pubitemid 46202346)
30. S Michiels S Koscielny C Hill 2007 Interpretation of microarray data in cancer Br J Cancer 96 8 1155 1158 17342085 10.1038/sj.bjc.6603673 1:CAS:528:DC%2BD2sXkt1GqsLc%3D (Pubitemid 46625063)
31. WQ Ding HJ Yu SE Lind 2008 Zinc-binding compounds induce cancer cell death via distinct modes of action Cancer Lett 271 2 251 259 18639975 10.1016/j.canlet.2008.06.011 1:CAS:528:DC%2BD1cXht1entLnI
32. L Wang RA Baiocchi S Pal G Mosialos M Caligiuri S Sif 2005 The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene Mol Cell Biol 25 18 7953 7965 16135788 10.1128/MCB.25.18.7953-7965.2005 1:CAS:528:DC%2BD2MXhtVWisL%2FL (Pubitemid 41262990)
33. RN Apte S Dotan M Elkabets, et al. 2006 The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions Cancer Metastasis Rev 25 3 387 408 17043764 10.1007/s10555-006-9004-4 1:CAS:528:DC%2BD28Xht1yktb3E (Pubitemid 44922357)
34. C Zhang D Chakravarty I Sakabe, et al. 2006 Role of SCC-S2 in experimental metastasis and modulation of VEGFR-2, MMP-1, an d MMP-9 expression Mol Ther 13 5 947 955 16455304 10.1016/j.ymthe.2005.11.020 1:CAS:528: DC%2BD28XjvV2qs7k%3D
35. J Németh H Stein D Haag, et al. 2009 S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis Hepatology 50 4 1251 1262 19670424 10.1002/hep.23099
36. M Kanda S Nomoto Y Nishikawa, et al. 2008 Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters J Surg Oncol 98 3 190 196 18537151 10.1002/jso.21095 1:CAS:528:DC%2BD1cXhtFOmsLrK
37. F Fan JS Wey MF McCarty, et al. 2005 Expression and foundation of vascular endothelial growth factor receptor-1 on human colorectal cancer cells Oncogene 24 16 2647 2653 15735759 10.1038/sj.onc.1208246 1:CAS:528: DC%2BD2MXjtFOkurg%3D (Pubitemid 40593092)
38. JS Wey F Fan MJ Gray, et al. 2005 Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines Cancer 104 2 427 438 15952180 10.1002/cncr.21145 1:CAS:528:DC%2BD2MXnslymu7c%3D (Pubitemid 40993273)
39. SP Gunningham MJ Currie C Han, et al. 2001 VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis J Pathol 193 3 325 332 11241411 10.1002/path.814 1:CAS:528:DC%2BD3MXisFynsLc%3D (Pubitemid 32229863)
40. S Hiratsuka A Watanabe H Aburatani Y Maru 2006 Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis Nat Cell Biol 8 12 1369 1375 17128264 10.1038/ncb1507 1:CAS:528:DC%2BD28Xht1Kju7rL (Pubitemid 44835111)
41. L Van't Veer H Dai M van de Vijver, et al. 2002 Gene expression profiling predicts clinical outcome of breast cancer Nature 415 6871 530 536 10.1038/415530a (Pubitemid 34130608)
42. X Hao B Sun L Hu, et al. 2004 Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis Cancer 100 6 1110 1122 15022276 10.1002/cncr.20095 1:CAS:528:DC%2BD2cXivFagsbo%3D (Pubitemid 38325937)
43. T Nishidate T Katagiri ML Lin, et al. 2004 Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis Int J Oncol 25 4 797 819 15375528 1:CAS:528:DC%2BD2cXovFWltbY%3D
44. X Li X Cao X Li W Zhang Y Feng 2007 Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer Cancer Sci 98 10 1592 1596 17651454 10.1111/j.1349-7006.2007.00565.x 1:CAS:528:DC%2BD2sXhtF2qtb%2FL (Pubitemid 47308456)
45. Abdelmohsen K, Kim MM, Srikantan S, et al. (2010) miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle 9(7):1538-4101
46. N Yang S Kaur S Volinia, et al. 2008 MicroRNA microarray indentifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer Cancer Res 68 24 10307 10314 19074899 10.1158/0008-5472.CAN-08-1954 1:CAS:528:DC%2BD1cXhsV2itL%2FP
47. R Bhattacharya M Nicoloso R Arvizo, et al. 2009 MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Cancer Res 69 23 9090 9095 19903841 10.1158/0008-5472.CAN-09-2552 1:CAS:528:DC%2BD1MXhsV2itLnJ
48. Y Tsukamoto C Nakada T Noguchi, et al. 2010 Micro-RNA-375 Is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3 Cancer Res 70 6 2339 2349 20215506 10.1158/0008-5472.CAN-09-2777 1:CAS:528:DC%2BC3cXjtFygtL8%3D
49. GM Arndt L Dossey LM Cullen, et al. 2009 Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer BMC Cancer 9 374 19843336 10.1186/1471-2407-9-374
50. A Villanueva Y Hoshida S Toffanin, et al. 2010 New strategies in Hepatocellular carcinoma: genomic prognostic markers Clin Cancer Res 16 19 4688 4994 20713493 10.1158/1078-0432.CCR-09-1811 1:CAS:528:DC%2BC3cXht1aktbvE